Streetbeat News

Revenues

THRY

Thryv has projected its FY23 SaaS revenue to be between $260M and $261M. The company also expects its Q4 revenue to range from $70.25M to $71.25M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:38 am

KPTI

Karyopharm Therapeutics has maintained its revenue guidance for FY 2023 at $145M-$160M, which is in line with the consensus of $151.31M. This includes U.S. XPOVIO net product revenue guidance of $110M-$125M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:38 am

SBUX

Starbucks has reported record-breaking average weekly sales following its fall season launch. The company also saw a record number of nearly 33 million active rewards members in Q4, setting records in spend per member and total member spend.

Portfolio Pulse from Charles Gross

November 02, 2023 | 11:37 am

OGN

Organon has revised its FY23 revenue guidance range downwards to $6.150B-$6.250B from the previous $6.250B-$6.450B. The new guidance is below the consensus estimate of $6.31B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:34 am

MGPI

MGP Ingredients has projected its FY23 revenue to be between $815M and $835M, which is in line with the estimated $827.19M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:32 am

RCM

R1 RCM has announced that it is on track to achieve its guidance for 2023, with expected revenue of $2.255 billion to $2.275 billion.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:27 am

CRTO

Criteo, a global technology company, has projected a revenue growth of 9% to 10% for the fiscal year 2023.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:27 am

VITL

Vital Farms has reaffirmed its net revenue guidance for FY23 at over $465M, against an estimate of $468.54M. The company's management expects to generate annual net revenue of more than $1 billion by the end of fiscal year 2027. They also anticipate a gross margin of at least 35% of net revenue and an Adjusted EBITDA Margin in the range of 12% to 14% by FY27.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:24 am

BAX

Baxter International Inc. anticipates sales growth from continuing operations of 1%-2% on a reported basis and approximately 2% on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:22 am

ZTS

Zoetis has revised its FY23 revenue guidance from $8.500B - $8.650B to $8.475B - $8.550B, which is slightly below the estimated $8.59B.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:20 am